Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medical Data Vision Co., Ltd. (3902:JPX), powered by AI.
1 analysts have a consensus target of ¥420, representing -75.1% upside from the current price.
View the latest insider trading data for Medical Data Vision Co., Ltd. on Alpha Lenz.
View Medical Data Vision Co., Ltd.'s valuation metrics on Alpha Lenz.
“Medical Data Vision Co., Ltd.'s ROE is 9.1%. Explore profitability and growth together.”
Ask for details →Medical Data Vision Co., Ltd. is a leading healthcare technology company that focuses on the management and analysis of medical data. The primary function of the company is to collect and utilize healthcare data to enhance the efficiency and effectiveness of medical services and facilitate better decision-making in the healthcare industry. This Japanese company specializes in the integration of Electronic Health Records (EHRs), providing valuable insights to both medical institutions and pharmaceutical companies. By transforming raw medical data into actionable analytics, Medical Data Vision plays a crucial role in the healthcare value chain, impacting sectors such as hospital administration, drug development, and preventive medicine. The company's offerings help to streamline healthcare operations, optimize patient care, and support clinical research. In the rapidly evolving landscape of digital health, Medical Data Vision stands out as a pivotal player in leveraging big data to foster innovation and improve health outcomes. Its role in the financial markets is underscored by growing interest in health informatics and technology-driven healthcare solutions, reflecting the increasing importance of data in shaping future healthcare paradigms.
“Medical Data Vision Co., Ltd.'s ROE is 9.1%. Explore profitability and growth together.”
Ask for details →Medical Data Vision Co., Ltd. (ticker: 3902) is a company listed on JPX in the Healthcare sector (Health Information Services). It has approximately 315 employees.
The current price is 1,684 with a P/E ratio of -x and P/B of -x.
ROE is 9.06% and operating margin is 5.34%. Annual revenue is $6.5B.